Syngene International Limited (SYNGENE) Share Analysis
NSE · Healthcare · Healthcare
Syngene International Limited (NSE: SYNGENE) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400. As of 14 Nov 2026, the share price was ₹444.00, P/E 67.5, ROE 7.78%.
Get the AI verdict on SYNGENE: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
SYNGENE chart with trendlines
Is SYNGENE a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Syngene International Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
SYNGENE key facts
| Price and valuation | |
|---|---|
| Share price | ₹444.00 |
| Market cap | ₹17,935 Cr |
| P/E ratio | 67.5 |
| P/B ratio | 3.7 |
| EPS | ₹4.62 |
| Book value per share | ₹120.00 |
| Dividend yield | 0.28% |
| 52-week range | |
| 52-week high | ₹678.95 |
| 52-week low | ₹344.45 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 52.59% |
| FIIs | 10.13% |
| DIIs | 29.31% |
| Public | 7.55% |
Index membership: NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.